Multiple Sclerosis Patients Improve After Adult Stem Cell Therapy
Doctors in Chicago use adult stem cells derived from bone marrow to halt and reverse the progression of multiple sclerosis.
January 30, 2009
Doctors in Chicago use adult stem cells derived from bone marrow to halt and reverse the progression of multiple sclerosis.
Nearly 5 years after the controversial Proposition 71 was voted into law, and with very little concrete progress to show for it, scientists are reevaluating the field of embryonic stem cell research in California.
The company Neuralstem has been awarded a patent for its proprietary technology to immortalize human neural stem cells.
The biotech company Geron has received FDA approval to conduct the first human clinical trial with embryonic stem cells.
Opexa Therapeutics holds an informative briefing on both executive and scientific company news.
The Australia-based company Mesoblast Limited announces institutional approval to begin the first human clinical trials of adult stem cell treatment for the prevention of osteoarthritis in the knee after acute traumatic injury.